SANTA MONICA, Calif.,
Jan. 21, 2022 /PRNewswire-PRWeb/
-- The Dovel & Luner law firm on Thursday filed a federal
class action lawsuit against Johnson & Johnson Consumer Inc. on
behalf of a California consumer
who purchased "Non-Drowsy" Tylenol medication. Romoff v. Johnson
& Johnson Consumer Inc., Case 3:22-cv-00075 (C.D. CA. Dkt. 1).
The lawsuit alleges that Johnson & Johnson misled millions of
consumers by deceptively labeling its Tylenol products as
"Non-Drowsy," even though the products do cause drowsiness.
The Complaint, filed in the United
States District Court for the Southern District of
California, alleges that Johnson
& Johnson violated the consumer protection laws of many states,
including the California Unfair Competition Law, the California
False Advertising Law, and the California Consumer Legal Remedies
Act.
The lawsuit claims that Johnson & Johnson prominently labels
many of its Tylenol medications "Non-Drowsy." As alleged in the
Complaint, "a reasonable consumer would believe that the products
do not cause drowsiness. That is, a reasonable consumer would
believe that drowsiness is not a side-effect of the products." The
Complaint alleges, however, that in reality these "Non-Drowsy"
Tylenol products contain Dextromethorphan Hydrobromide (DXM), an
ingredient known to cause drowsiness.
As alleged in the Complaint, Johnson & Johnson's "false
statements increased the demand for Non-Drowsy Tylenol Products and
allowed [Johnson & Johnson] to charge a price premium."
The lawsuit seeks to enjoin Johnson & Johnson from
continuing to engage in the allegedly deceptive advertising and to
require that it compensate harmed consumers.
Media Contact
Simon Franzini, Dovel &
Luner, LLP, 1 310-656-7066, simon@dovel.com
SOURCE Dovel & Luner, LLP